21 - 30 out of 187Page size: 10
  1. 2022

  2. Stopping and restarting PrEP and loss to follow-up among PrEP-taking men who have sex with men and transgender women at risk of HIV-1 participating in a prospective cohort study in Kenya

    Wahome, E., Boyd, A., Thiong’o, A. N., Mohamed, K., Oduor, T., Gichuru, E., Mwambi, J., van der Elst, E., Graham, S. M., Prins, M. & Sanders, E. J., Aug 2022, In: HIV medicine. 23, 7, p. 750-763 14 p.

    Research output: Contribution to journal › Article › Academic › peer-review

  3. The effect of SARS-CoV-2 vaccination on post-acute sequelae of COVID-19 (PASC): A prospective cohort study

    Wynberg, E., Han, A. X., Boyd, A., van Willigen, H. D. G., Verveen, A., Lebbink, R., van der Straten, K., the RECoVERED Study Group, Kootstra, N., van Gils, M. J., Russell, C., Leenstra, T., de Jong, M. D., de Bree, G. J. & Prins, M., 30 Jul 2022, In: Vaccine. 40, 32, p. 4424-4431 8 p.

    Research output: Contribution to journal › Article › Academic › peer-review

  4. Evolution of Coronavirus Disease 2019 (COVID-19) Symptoms During the First 12 Months After Illness Onset

    Wynberg, E., van Willigen, H. D. G., Dijkstra, M., Boyd, A., Kootstra, N. A., RECoVERED Study Group, van den Aardweg, J. G., van Gils, M. J., Matser, A., de Wit, M. R., Leenstra, T., de Bree, G., de Jong, M. D. & Prins, M., 1 Jul 2022, In: Clinical infectious diseases. 75, 1, p. e482-e490

    Research output: Contribution to journal › Article › Academic › peer-review

  5. One in 10 Virally Suppressed Persons With HIV in The Netherlands Experiences ≥10% Weight Gain After Switching to Tenofovir Alafenamide and/or Integrase Strand Transfer Inhibitor

    Verburgh, M. L., Wit, F. W. N. M., Boyd, A., Verboeket, S. O., Reiss, P. & van der Valk, M., 1 Jul 2022, In: Open forum infectious diseases. 9, 7, p. ofac291 ofac291.

    Research output: Contribution to journal › Article › Academic › peer-review

  6. Co-infection par les virus des hépatites B et D chez les personnes vivant avec le VIH

    Boyd, A., Melin, P. & Lacombe, K., 1 Jun 2022, In: Hepato-Gastro et Oncologie Digestive. 29, p. 35-43 9 p.

    Research output: Contribution to journal › Review article › Professional

  7. Similar Risk of Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Similar Nucleocapsid Antibody Levels in People with Well-Controlled Human Immunodeficiency Virus (HIV) and a Comparable Cohort of People Without HIV

    Verburgh, M. L., Boyd, A., Wit, F. W. N. M., Schim van der Loeff, M. F., van der Valk, M., Bakker, M., Kootstra, N. A., van der Hoek, L. & Reiss, P., 1 Jun 2022, In: Journal of infectious diseases. 225, 11, p. 1937-1947 11 p.

    Research output: Contribution to journal › Article › Academic › peer-review

  8. Trends in Sexual Behavior and Sexually Transmitted Infections after Initiating Human Immunodeficiency Virus Pre-Exposure Prophylaxis in Men Who Have Sex with Men from Amsterdam, the Netherlands: A Longitudinal Exposure-Matched Study

    Coyer, L., Prins, M., Davidovich, U., Van Bilsen, W. P. H., Schim Van Der Loeff, M. F., Hoornenborg, E., Matser, A. & Boyd, A., 1 Jun 2022, In: AIDS patient care and STDs. 36, 6, p. 208-218 11 p.

    Research output: Contribution to journal › Article › Academic › peer-review

  9. Low hepatitis C virus-viremia prevalence yet continued barriers to direct-acting antiviral treatment in people living with HIV in the Netherlands

    Isfordink, C. J., Smit, C., Boyd, A., de Regt, M. J. A., Rijnders, B. J. A., van Crevel, R., ATHENA observational cohort, Ackens, R. P., Reiss, P., Arends, J. E. & van der Valk, M., 1 May 2022, In: AIDS (London, England). 36, 6, p. 773-783 11 p.

    Research output: Contribution to journal › Article › Academic › peer-review

  10. Severe Fatigue in the First Year Following SARS-CoV-2 Infection: A Prospective Cohort Study

    Verveen, A., Wynberg, E., van Willigen, H. D. G., Boyd, A., de Jong, M. D., de Bree, G., Davidovich, U., Lok, A., Moll van Charante, E. P., Knoop, H., Prins, M., Nieuwkerk, P., Agard, I., Ayal, J., Cavdar, F., Craanen, M., Deuring, A., van Dijk, A., Ersan, E., del Grande, L., & 36 othersHartman, J., Koedoot, N., Leenstra, T., Lebbink, R., Loomans, D., Makowska, A., du Maine, T., de Man, I., Matser, A., van der Meij, L., van Polanen, M., Oud, M., Reid, C., Storey, L., van Wijk, M., van den Aardweg, J., van Assem, J., van Beek, M., Blankert, T., Dijkstra, M., Figaroa, O., Frenkel, L., van Gils, M., van Haga, J., Han, X., Harskamp-Holwerda, A., Hazenberg, M., Hidad, S., de Jong, N., Kootstra, N., Kuijt, L., Russell, C., van der Straten, K., van der Veen, A., Verkaik, B. & Visser, G-R., 1 May 2022, In: Open forum infectious diseases. 9, 5, ofac127.

    Research output: Contribution to journal › Article › Academic › peer-review

  11. Efficacy of ertapenem, gentamicin, fosfomycin, and ceftriaxone for the treatment of anogenital gonorrhoea (NABOGO): a randomised, non-inferiority trial

    de Vries, H. J. C., de Laat, M., Jongen, V. W., Heijman, T., Wind, C. M., Boyd, A., de Korne-Elenbaas, J., van Dam, A. P., Schim van der Loeff, M. F., NABOGO steering group, Bruisten, S., Hoornenborg, E., Knol, M., Mathôt, R. A. A. & Prins, J. M., May 2022, In: The Lancet Infectious Diseases. 22, 5, p. 706-717 12 p.

    Research output: Contribution to journal › Article › Academic › peer-review

Previous 1 2 3 4 5 6 7 8 ...19 Next

ID: 12524562